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Abstract
Background: The ultraconserved elements (UCEs) are defined as stretches of at least 200 base pairs of human DNA
that match identically with corresponding regions in the mouse and rat genomes, albeit their real significance remains
an intriguing issue. These elements are most often located either overlapping exons in genes involved in RNA
processing or in introns or nearby genes involved in the regulation of transcription and development. Interestingly,
human UCEs have been reported to be strongly depleted among segmental duplications and benign copy number
variants (CNVs). However no comprehensive survey of a putative enrichment of these elements among pathogenic
dose variants has yet been reported.
Results: A survey for UCEs was performed among the 26 cryptic genomic rearrangements detected in our series
of 200 patients with idiopathic neurodevelopmental disorders associated to congenital anomalies. A total of 29
elements, out of the 481 described UCEs, were contained in 13 of the 26 pathogenic gains or losses detected in
our series, what represents a highly significant enrichment of ultraconserved elements. In addition, here we show
that these elements are preferentially found in pathogenic deletions (enrichment ratio 3.6 vs. 0.5 in duplications),
and that this association is not related with a higher content of genes. In contrast, pathogenic CNVs lacking UCEs
showed almost a threefold higher content in genes.
Conclusions: We propose that these elements may be interpreted as hallmarks for dose-sensitive genes,
particularly for those genes whose gain or loss may be directly implied in neurodevelopmental disorders.
Therefore, their presence in genomic imbalances of unknown effect might be suggestive of a clinically relevant
condition.
Background
A current challenge of medical genetics is aimed to dis-
entangle the relationship between the genomic data pro-
vided by the introduction of array comparative genomic
hybridization (array-CGH) and the phenotypic conse-
quences of the gains and losses observed along the
whole genome. The classical criteria of assigning a
pathogenic condition to any de novo alteration cannot
be always applied, as exceptions in both senses can
occur: benign copy number variants (CNVs) can arise
de novo (unpublished results) while some pathogenic
alterations are associated to such a broad phenotypic
spectrum that they may have been inherited from appar-
ently healthy parents [1]. Comparative genomics may
provide an invaluable tool in the task of differentiating
benign from pathogenic CNVs or, in other words, to
evaluate which genes may be dose-sensitive or not. In
this context, the real significance of the ultraconserved
elements (UCEs) in the human genome remains an
intriguing issue. There are 481 UCEs, defined as
stretches of at least 200 base pairs of human DNA that
match identically with corresponding regions in the
mouse and rat genomes [2]. They are widely distributed
in the genome (on all the chromosomes except chromo-
somes 21 and Y) and are often found in clusters. For
unknown reasons, these regions are under a negative
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sequences and have been evolutionarily conserved for
300 million years, before mammal and bird ancestors
diverged [3]. Of the 481 ultraconserved elements, 111
overlap the mRNA of a known gene, 256 show no evi-
dence of transcription, and for the remaining 114 the
evidence for transcription is inconclusive. These ele-
ments are most often located either overlapping exons
in genes involved in RNA processing or in introns or
nearby genes involved in the regulation of transcription
and development. These elements are frequently found
in genes post-transcriptionally regulated by alternative
splicing events of exons with premature stop codons.
Accordingly, the extreme genomic conservation has
been associated to regulatory splicing events maintaining
tightly regulated levels of RNA-binding proteins [4]. On
the other hand, intergenic elements are frequently
flanked by developmental genes, in particular for genes
involved in early developmental tasks, suggesting that
many of the associated ultraconserved elements may be
distal enhancers of these early developmental genes [2].
Functional studies suggested that these elements show a
tissue-specific in vivo enhancer activity in a mouse trans-
genic reporter assay that tended to recapitulate aspects of
the expression pattern found in genes that were in their
proximity [5]. On the other hand, the removal of four of
these UCEs, located near genes that exhibit marked phe-
notypes in murine models, failed to reveal any overt varia-
tion of growth, longevity, pathology or metabolism. As the
authors concluded, these results indicate that extreme
sequence constraint does not necessarily reflect crucial
functions required for viability, although not all the possi-
ble phenotypic impact was evaluated [6].
Interestingly, human UCEs have been reported to be
strongly depleted among segmental duplications and
benign copy number variants [7]. However, no compre-
hensive survey of a putative enrichment of these elements
among pathogenic dose variants, and more specifically
among those rearrangements directly related with neuro-
developmental disorders, has yet been attempted.
Results
We performed an inspection for the 481 previously
reported ultraconserved elements among the cryptic geno-
mic rearrangements detected in our series of patients with
idiopathic neurodevelopmental disorders associated to
congenital anomalies. We found a total of 29 different
elements contained in 13 out of the 26 pathogenic gains
or losses detected in our series (Table 1). These dose
alterations span variable sizes, ranging from 210 Kb to
13.4 Mb, which altogether represent almost 83 Mb of
non-overlapping genomic sequence, or about 2.67% of the
human genome. Assuming a random distribution for the
UCEs along the genome, about 12.8 (481 × 0.0267)
elements of this kind would be expected to be found. The
difference between the number of observed and expected
elements represents a highly significant enrichment of
these elements among the pathogenic CNVs (chi-square =
20.32; P < 0.00001). The proportion between exonic and
non-exonic UCEs in our series (8 vs. 17) is quite similar
to the global proportion (111 vs. 256), what suggests that
neither type is over-represented in pathogenic imbalances.
When comparing gains and losses, we found an excess
of deletions (10 out of 15) that contain UCEs, while
only 3 out of 11 duplications bear these elements. This
difference is in the limit of significance (P = 0.055; Fish-
er’s exact text). However, when analysing separately
both kinds of CNVs, it becomes rather evident that the
enrichment for ultraconserved elements is mainly due to
the deletions (see Table 2). Deletions show a highly sig-
nificant excess of UCEs, estimated in 3.6 times more
frequent than expected. Conversely, the pathogenic
gains of dose that we have detected in our series do not
deviate significantly in the number of ultraconserved
elements contained.
The parental origin of the chromosome bearing the
alteration could be determined in 21 cases through
microsatellite segregation analyses. Ten rearrangements
occurred as de novo events in the paternal chromosome
and four in the maternal chromosome, while the remain-
ing alterations were inherited from the carrier mother
(in five cases) or from the father (two cases). These inher-
ited CNVs were X-linked or associated to mild affecta-
tion in the carrier parent. Remarkably, 24 out of the 29
UCEs were contained in the rearrangements inherited
from the father or originated in a paternally derived chro-
mosome. However, this association might well be an
indirect consequence of a higher proportion of deletions
originated in the paternally derived chromosome. Both
paternal and maternal deletions show a similar enrich-
ment ratio for UCEs (3.9 and 3.0, respectively), while the
paternal and maternal duplications contain a lower than
expected ratio (0.9 and 0.0, respectively).
On the other hand, it is noteworthy that none element
w a sf o u n di no u rs e r i e sa m o n gt h e9 3C N V sc o n s i d e r e d
as polymorphic variants, some of them not previously
reported, which altogether cover about 23.7 Mb (see
Additional file 1). This absence of ultraconserved ele-
ments among benign CNVs almost reached significance
(see Table 2), in accordance with previous studies
described above.
Discussion
We found a highly significante n r i c h m e n to fu l t r a c o n -
served elements among pathogenic imbalances causing
neurodevelopmental disorders. It can be therefore
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genes, might be considered particularly sensitive to dose
imbalances.
It might be argued that the positive association
between clinically relevant CNVs and UCEs merely
reflects that pathogenic alterations preferentially affect
gene-rich regions and, as an indirect consequence, they
might contain more ultraconserved elements. In accor-
dance, we performed a similar analysis for the gene
content after differentiating between the pathogenic
CNVs that contain and those that do not contain UCEs,
based in the number of annotated RefSeq Genes [8], as
well as in the more conservative Consensus Coding
Sequence (CCDS) project [9]. As can be seen in Table 3,
the UCEs-containing CNVs showed a lower than
expected gene content, what allow us to reject this spur-
ious association. Furthermore, this result is in good
agreement with the previous report that non-exonic
Table 1 Pathogenic imbalances and UCEs
Case Imbalance Chr. Region Initial pos.
a (Mb) Final pos.
a (Mb) Size (Kb) Inheritance Origin Ultraconserved elements
b
3 Loss 1 q24-25 167.024 172.151 5,000 De novo Maternal
15 Loss 1 q44 242.638 243.791 1,153 De novo Paternal uc.45-uc.46
88 Gain 2 p22.2-23.3 24.374 37.745 13,371 De novo Paternal uc.49
C2 Loss 2 q31 177.246 180.516 3,270 De novo Paternal uc.109
92 Loss 3 q13.2-13.3 113.681 116.922 3,242 De novo Maternal uc.119-uc.122
C1 Loss 3 q29 197.293 198.467 1,174 Inherited Maternal
18 Loss 5 q14.3 86.142 90.112 3,970 De novo Paternal uc.163-uc.167
2 Loss 6 q16 93.933 103.287 9,200 De novo Paternal uc.194, uc.195-uc.200, uc.201, uc.202
7 Loss 6 q16 93.930 104.244 10,314 De novo Paternal uc.194, uc.195-uc.200, uc.201, uc.202
M2 Loss 7 p21.2 ~19.120 ~19.700 ~580 De novo n.d.
C4 Gain 7 q11.3 73.481 74.981 1,500 De novo n.d.
C3 Gain 8 q12 59.536 62.526 2,990 De novo Paternal uc.239
78 Loss 11 q13.5 75.730 83.639 7,909 De novo Paternal uc.331
16 Loss 13 q32 93.423 98.967 5,544 De novo Paternal uc.355, uc.356
C5 Gain 14 q11.2 18.832 23.660 4,828 De novo Maternal
9 Loss 15 q23 67.908 69.198 1,290 Inherited Maternal uc.392
M1 Loss 17 p11.2 ~18.400 ~20.200 ~1,800 De novo n.d.
M3 Loss 17 q21.31 ~41.100 ~41.600 ~500 De novo n.d.
63 Gain 19 p13.3 1.904 6.860 4,956 De novo Maternal
10 Loss 20 q12-13.11 39.463 42.008 2,540 Inherited Paternal uc.456
71 Gain 22 q11 17.276 19.230 1,954 Inherited Paternal uc.457
41 Gain X p11.23 45.063 48.922 3,859 De novo Paternal
42 Gain X p11.22 53.238 54.239 1,001 Inherited Maternal
14 Gain X q28 152.373 153.433 1,060 Inherited Maternal
54 Gain X q28 152.850 153.060 210 Inherited Maternal
72 Gain X q28 152.930 153.230 300 De novo n.d.
26 pathogenic imbalances detected in our series of patients with idiopathic mental retardation/developmental delay and congenital anomalies.
(a) Position of the first and last altered probes according to hg18 (UCSC).
(b) Nomenclature according to Bejerano et al. (2004). Hyphenation denotes clusters where all the consecutive UCEs are included.
Table 2 Analysis of frequencies of UCEs
Size (Mb) % of genome No. UCEs Enrichment ratio
a P-value
b No. Sno/miRNA Enrichment ratio
a
Genome 3107 481 1120
Polymorphic CNVs 23.74 0.76 0 - 0.06 7 0.82
Pathogenic CNVs 82.97 2.67 29 2.26 0.000007 42 1.41
Deletions 47.45 1.53 26 3.55 0.000001 18 1.05
Duplications 35.52 1.14 3 0.54 0.28 24 1.87
Analysis of frequencies of ultraconserved elements (UCEs) among polymorphic and pathogenic CNVs detected in our series of patients. Note that the lack of
UCEs among polymorphic CNVs is in the limit of significance, while the excess of UCEs among pathogenic CNV is largely due to those present in deletions.
Comparatively, similar analyses of frequencies for microRNAs/snoRNAs do not show significant differences, thus confirming the representativeness of the
examined regions.
(a) Enrichment ratio represents the ratio between observed and expected elements. It is calculated as (item count/size of region)/(total items/size of genome).
(b) Chi-square test for goodness of fit.
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[2]. It is worth mentioning that 88 of them were reported
to be more than 100 kilobases away from any known
gene. Conversely, those pathogenic CNVs that do not
contain UCEs showed a strikingly higher than expected
gene content. This result suggests that gene content and
presence of UCEs might be complementary criteria of
pathogenicity, that is, pathogenic CNVs tend to affect
either a high number of genes or closely regulated genes
near UCEs, many of them in “gene deserts”.I nt u r n ,t h i s
complementarity can be interpreted as reinforcement for
the association between pathogenic CNVs and ultracon-
served elements.
Another putative argument for a random association
between pathogenic CNVs and UCEs might be derived
from the fact that many UCEs appear clustered. However
we found a similar number of isolated and clustered ultra-
conserved elements in our series (13 and 16, respectively).
In fact, the isolated elements were over-represented as
compared with clustered elements. In the 2.67% of the
genome are present 10% of the isolated elements (13/131)
and 4.6% of the clustered elements (16/350), what repre-
sent the respective enrichment ratios of 3.7 and 1.7. In any
case, clustering does not modify the a priori probability to
find these elements, because every imbalanced region
represents an independent ‘sampling’ event. In order to
check the representativeness of the CNVs detected in our
series, we analysed the frequencies of other sentinel ele-
ments, microRNAs/snoRNAs, present in a similar order of
magnitude in the genome than UCEs, and that also tend
to cluster. These elements were evenly represented in any
category of CNVs in frequencies very close to the expected
(enrichment ratios near 1, see Table 2). Even the slight
excess among duplications (observed/expected = 1.87)
may well be interpreted as reflecting a higher content of
genes.
To explain the lack of association of UCEs with duplica-
tions in our series, several factors (not mutually exclusive)
may be argued, such as a patient-selection bias or the fact
that duplications are on average slightly larger and clearly
more gene-rich than deletions. On the other hand, there is
an excess of duplications in the X chromosome. A high
incidence of duplications on the X chromosome contribut-
ing to mental retardation has been recently reported [10],
what might be related to the fact that the resulting gene
dosage in males is higher than with any other chromo-
some (a dose increase of 100% instead of 50%). This spe-
cial condition might also helps to explain that more genes
are clinically relevant if duplicated in the X chromosome,
and consequently more genes can be potentially patho-
genic by duplication even when they are not tightly regu-
lated genes, for instance by ultraconserved elements.
Although our results did not reach significance (see
Table 2), we have confirmed a depletion of UCEs
among benign CNVs as previously described [7]. Derty
and collaborators additionally found that most of the
ultraconserved elements present in benign copy number
variants overlapped exons. These exonic UCEs are pre-
sent in many genes encoding well-known RNA-binding
proteins, while intergenic UCEs are preferentially
flanked by developmental genes, particularly involved in
early developmental tasks [2]. We found that both exo-
nic and intergenic ultraconserved elements appear to be
equally represented in the CNV regions associated to
disease, what advocates for a dose-sensitive character of
the nearby genes in either case.
In summary, we have found that pathogenic CNVs
show an enrichment of ultraconserved elements, conver-
sely to benign CNVs. It can be argued that since UCEs
are often associated with genes involved in RNA proces-
sing and developmental tasks, especially these genes are
dosage-sensitive and hence, a heterozygous deletion/
duplication including such a gene will more likely result
in disease.
Conclusions
In the view of the association between ultraconserved
elements and pathogenic dose variants, we therefore
propose that these elements may be interpreted as hall-
marks for dosage-sensitive genes, particularly for those
genes whose gain or loss may be directly implied in
neurodevelopmental disorders. Obviously, the presence
of this kind of elements in CNVs of unknown conse-
quences should be used with caution together with
Table 3 Relation between presence of UCEs and gene content
Size
(Mb)
No. Gene annotations
(RefSeq)
Enrichment
ratio
a
No. Gene annotations
(CCDS)
Enrichment
ratio
a
Genome 3107 33,244 19,841
Pathogenic CNVs with UCEs 56.591 488 0.81 311 0.86
Pathogenic CNVs without
UCEs
26.384 781 2.76 477 2.83
When comparing the observed/expected ratio of gene content in pathogenic imbalances attending to the presence or not of ultraconserved elements, it results
evident that only pathogenic CNVs without UCEs show an excess of gene content. Consequently we can reject that the enrichment of UCEs in clinically relevant
CNVs are due to a higher gene content.
(a) The ratio between observed and expected elements was computed as specified in table 2.
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the mode of inheritance. This is an important issue
given the current limitation in some instances to differ-
entiate between pathogenic and benign rare copy num-
ber variants.
Methods
Laboratory analyses
Genomic DNA from 200 patients and their parents was
purified by standard proteinase K/phenol-chloroform pro-
cedures. All the patients showed idiopathic mental retar-
dation associated to congenital anomalies, non assignable
to known syndromes after clinical examination by two
specialists. Informed parental consent, as approved by our
Hospital Review Board, was obtained prior to research stu-
dies. Patients C1 to C5 were studied by clone-based array
CGH as reported elsewhere [11]. Patients M1 to M3 were
detected in the initial screening for microdeletion
syndromes by commercial MLPA (SALSA P245; MRC-
Holland, Amsterdam), following the recommendations of
the manufacturer. All the remaining cases were studied by
array-based comparative genomic hybridization (human
genome CGH microarray AMADID: 014950, from Agilent
Technologies, Palo Alto, CA) as recommended. The
patients’ DNA samples were tested against a pool of 10
sex-matched normal DNA samples, all of them (patients
and normal controls) from our geographical area. Confir-
matory analyses and familial studies were done by micro-
satellite marker segregation analyses and commercial or
home-made MLPA studies (primers and conditions avail-
able upon request).
The CNVs detected with both kinds of arrays were
collected together, defined by the distal ends of the first
and last probe altered. It is worth to note that most
benign and pathogenic CNVs were detected by the com-
mercial oligonucleotides-based array because of its
higher resolution and because it was applied to 95%
patients. On the other hand, they can be considered
complementary, as many of the small polymorphic
CNVs previously detected in the clone-based array [11]
could not be refined in the oligo-array because of lack
of probes in such regions, designed in order to avoid
frequent polymorphic CNVs.
Statistical analyses
Item counts for the presence of ultraconserved elements,
sno/miRNAs and genes in the regions encompassed by
CNVs were performed through the UCSC Genome
Browser [12], based on build hg18. The delimiting posi-
tions of all the ultraconserved elements, tracked in the
hg16 version, were converted to built hg18 through the
‘Convert’ Feature http://genome.ucsc.edu/goldenPath/
help/hgTracksHelp.html#Convert and compiled in an
in-home excel sheet to facilitate visual inspection. In
every case, a confirmation of the positions was per-
formed by employing as reference the previously known
delimiting genes in the CNVs. Items contained in over-
lapping rearrangements were considered once, avoiding
duplications of items or sizes.
In order to measure the strength of association, we
employed the observed/expected ratio (called ‘enrich-
ment ratio’ in tables 2 and 3). The expected frequencies
were computed as the product of the total number of
elements (for instance, n = 481 UCEs) by the proportion
of genome examined (pi = ∑iMb/Mbgenome). Frequency
analyses were performed by the Pearson’sc h i - s q u a r e
goodness-of-fit test, employing the observed and
expected frequencies previously computed.
Additional material
Additional file 1: Polymorphic imbalances. Polymorphic imbalances
detected in our series of patients with idiopathic mental retardation/
developmental delay and congenital anomalies. There are a total of 93
different CNVs present in 115 cases. These CNVs have previously been
reported as polymorphisms and/or are present in at least one healthy
member of the family. Altogether, these CNVs span a total of 23.74 Mb,
excluding the overlapping regions. Note that all these regions do not
contain any ultraconserved element.
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